A 37-year-old woman with a history of anorectal abscesses complains of pain in the perianal region. Physical examination reveals mild swelling, tenderness, and erythema of the perianal skin. She is prescribed oral ampicillin and asked to return for follow-up. Two days later, the patient presents with a high-grade fever, syncope, and increased swelling. Which of the following would be the most common mechanism of resistance leading to the failure of antibiotic therapy in this patient?

Production of beta-lactamase enzyme

Intrinsic absence of a target site for the drug

Use of an altered metabolic pathway

Altered structural target for the drug

A 42-year-old woman with a history of multiple sclerosis and recurrent urinary tract infections comes to the emergency department because of flank pain and fever. Her temperature is 38.8°C (101.8°F). Examination shows left-sided costovertebral angle tenderness. She is admitted to the hospital and started on intravenous vancomycin. Three days later, her symptoms have not improved. Urine culture shows growth of Enterococcus faecalis. Which of the following best describes the most likely mechanism of antibiotic resistance in this patient?

Alteration of peptidoglycan synthesis

Increased efflux across bacterial cell membranes

Alteration of penicillin-binding proteins

Alteration of ribosomal targets

A team of intensivists working in a private intensive care unit (ICU) observe that the clinical efficacy of vancomycin is low, and proven nosocomial infections have increased progressively over the past year. A clinical microbiologist is invited to conduct a bacteriological audit of the ICU. He analyzes the microbiological reports of all patients treated with vancomycin over the last 2 years and takes relevant samples from the ICU for culture and antibiotic sensitivity analysis. The audit concludes that there is an increased incidence of vancomycin-resistant Enterococcus fecalis infections. Which of the following mechanisms best explains the changes that took place in the bacteria?

Replacement of the terminal D-Ala in the cell wall peptidoglycan by D-lactate

Decreased number of porins in the bacterial cell wall leading to decreased intracellular entry of the antibiotic

Production of an enzyme that hydrolyzes the antibiotic

Protection of the antibiotic-binding site by Qnr protein

Increased expression of efflux pumps which extrude the antibiotic from the bacterial cell

A 65-year-old man presents with low-grade fever and malaise for the last 4 months. He also says he has lost 9 kg (20 lb) during this period and suffers from extreme fatigue. Past medical history is significant for a mitral valve replacement 5 years ago. His temperature is 38.1°C (100.6°F), respirations are 22/min, pulse is 102/min, and blood pressure is 138/78 mm Hg. On physical examination, there is a new onset 2/6 holosystolic murmur loudest in the apical area of the precordium. Which of the following organisms is the most likely cause of this patient’s condition?

Coagulase-negative Staphylococcus spp.

A 45-year-old male presents to his primary care physician complaining of drainage from his left great toe. He has had an ulcer on his left great toe for over eight months. He noticed increasing drainage from the ulcer over the past week. His past medical history is notable for diabetes mellitus on insulin complicated by peripheral neuropathy and retinopathy. His most recent hemoglobin A1c was 9.4%. He has a 25 pack-year smoking history. He has multiple sexual partners and does not use condoms. His temperature is 100.8°F (38.2°C), blood pressure is 150/70 mmHg, pulse is 100/min, and respirations are 18/min. Physical examination reveals a 1 cm ulcer on the plantar aspect of the left great toe surrounded by an edematous and erythematous ring. Exposed bone can be palpated with a probe. There are multiple small cuts and bruises on both feet. A bone biopsy reveals abundant gram-negative rods that do not ferment lactose. The pathogen most likely responsible for this patient’s current condition is also strongly associated with which of the following conditions?

Waterhouse-Friedrichsen syndrome

Biofilm-associated antimicrobial resistance for USMLE Step 3: High-Yield Microbiology Lessons

Biofilm Formation - The Slime Shield

Foundation: Begins with planktonic (free-floating) bacteria attaching to a surface (e.g., catheters, implants).
The Matrix: Bacteria secrete Extracellular Polymeric Substance (EPS), a slimy mix of polysaccharides, proteins, lipids, and eDNA.
- This EPS encases the colony, providing structural support and protection.

Biofilm prevention on catheters using hydrophilic coating

⭐ Quorum Sensing: Bacteria communicate via autoinducers (e.g., acyl-homoserine lactones in Gram-negatives) to coordinate gene expression, initiating EPS production once a critical population density is reached.

Resistance Mechanisms - Fort Biofilm's Defenses

Physical Barrier: Extracellular Polymeric Substance (EPS) matrix physically blocks or slows antibiotic penetration.
- Certain antibiotics may be inactivated by binding to EPS components.
Altered Microenvironment: Creation of chemical gradients within the biofilm.
- ↓ O₂ and nutrient availability leads to slow-growing or dormant cells in deeper layers.
- These metabolically inactive cells are less susceptible to antibiotics targeting active processes (e.g., β-lactams).
Persister Cells: A subpopulation of dormant, highly tolerant cells that survive antibiotic assault and can repopulate the biofilm post-treatment.
Efflux Pumps & Enzyme-Mediated Resistance: Overexpression of efflux pumps to expel antibiotics from the cell.
- Concentrated neutralizing enzymes (e.g., β-lactamases) are trapped within the EPS matrix, protecting the entire community.

⭐ Horizontal Gene Transfer (HGT): High cell density promotes the exchange of genetic material, such as plasmids and transposons carrying resistance genes, accelerating the spread of resistance.

Biofilm antimicrobial resistance mechanisms

Clinical Correlates - High-Risk Havens

Prosthetic Devices: Hotbeds for biofilm formation.
- Joints & Heart Valves: Staphylococcus epidermidis & S. aureus are primary culprits. Viridans streptococci on native/prosthetic valves.
- Catheters (Venous/Urinary): S. epidermidis, S. aureus, Candida, E. coli, Proteus.
Chronic Infections:
- Cystic Fibrosis Pneumonia: Mucoid Pseudomonas aeruginosa creates stubborn lung biofilms.
- Dental Plaque & Caries: Streptococcus mutans.
- Chronic Otitis Media: Non-typeable Haemophilus influenzae.
- Prostatitis: E. coli.

Biofilm on indwelling medical catheter, SEM

⭐ Exam Favorite: The mucoid phenotype of Pseudomonas aeruginosa in cystic fibrosis is due to alginate overproduction, a key component of its protective biofilm matrix, leading to persistent infections and antibiotic failure.

High‑Yield Points - ⚡ Biggest Takeaways

The extracellular polymeric substance (EPS) matrix is a physical barrier that blocks or slows antibiotic penetration.

Slow bacterial growth within the biofilm reduces the efficacy of antibiotics targeting active cell division, like β-lactams.

An altered chemical microenvironment (e.g., ↓O₂, ↓pH) can directly inactivate certain antimicrobial drugs.

Biofilms harbor persister cells, dormant variants that survive high-dose antibiotic therapy and can repopulate the community.

Close proximity facilitates horizontal gene transfer, accelerating the spread of resistance genes.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play